The Year Of Beauty Continues: Company Profile Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
June 23 high right here! B/O EOLS Evolus, Inc. $10.43-0.12(-1.14%)4:00 PM 01/16/24 NASDAQ |$USD |Post-Market:$11.00+0.57(+5.47%) ,<-----------
Decent end of day spike-(we are Long 250) Universal Display Corporation (OLED) NasdaqGS - NasdaqGS Real Time Price. 178.66+1.04(+0.59%) At close: 04:00PM EST
They year of beauty reveals itself/////// COTY Placed Well for 2024 on Solid Beauty Trends, Strategies Coty Inc.COTY is likely to continue experiencing gains from the growing beauty market. Growth in the beauty industry has boomed in recent years due to greater attention to physical well-being, and Coty is positioned well to leverage these trends. The company has been focused on its six strategic pillars. These include stabilizing Consumer Beauty make-up brands and mass fragrances, accelerating luxury fragrances and setting up Coty as a core player in prestige make-up, establishing a skincare portfolio in prestige and mass channels, strengthening e-commerce and Direct-to-Consumer (DTC) capabilities, growing presence in China via Prestige and certain Consumer Beauty brands and setting Coty as an industry leader in sustainability. Adding Leaves to the Growth Story Coty is on track with repositioning campaigns and disruptive advertising. The company has been reaping the benefits of the booming global prestige fragrance market. In the first quarter of fiscal 2024, demand for prestige fragrances across North America and Europe continued to grow. In the quarter, Coty’s e-commerce sales across the Consumer Beauty business grew strongly year over year. Coty is on track to fuel its Digital momentum across key areas like social commerce, e-retail and new partnerships. Apart from these, the company continues to witness impressive momentum in Travel Retail sales. The company’s Travel Retail business witnessed over 20% growth in the first quarter of fiscal 2024, driven by the continued recovery of international travel and Coty's expansion in the travel retail channel. Coty has been witnessing strength in the Prestige and Consumer Beauty segments, which helped fuel like-for-like (LFL) revenue growth of 18% in the first quarter. These upsides, along with continued gains from strategic collaborations, bode well for 2024. Zacks Investment Research Image Source: Zacks Investment Research 2024 Picture Looks Bright With the ongoing premiumization trends, management continues to witness strength in the beauty market. The company is gaining on such favorable trends, with momentum in the core categories, an impressive innovation pipeline and early wins across important white spaces. On its first-quarter earnings call, COTY raised its view for the first half and fiscal 2024. For the first half of fiscal 2024, the company’s core LFL sales are expected to grow in the range of 11-13%, higher than the earlier outlook of 10-12% growth. Both the Prestige and Consumer Beauty segments are seeing sequential growth. Consequently, management anticipates core LFL sales growth in the range of 9-11% for fiscal 2024, surpassing its earlier guidance of 8-10% growth. The company anticipates modest fiscal 2024 gross margin expansion on a year-over-year basis, with a substantial increase in the back half of fiscal 2024. For fiscal 2024, COTY expects an adjusted EBITDA margin expansion of 10-30 bps, with the same performance during the first and second half. The company projects fiscal 2024 adjusted EBITDA in the range of $1,080-$1,090 million, up from the previous guidance of $1,075-$1,085 million. It envisions fiscal 2024 adjusted EPS, excluding equity swap, in the band of 44-47 cents, reflecting growth of 16-25% year over year. The company is dedicated to achieving its medium-term growth plan, which encompasses achieving a CAGR in the mid-20s percent for earnings per share (EPS) through profit growth, reduced interest expenses and a medium-term goal of managing the share count around 800 million. Shares of COTY have increased 9.4% in the past three months, outpacing the industry’s growth of 2.4%.
If it's beauty it's up: e.l.f. Beauty, Inc. (ELF) NYSE - NYSE Delayed Price. 163.93+6.32(+4.01%) At close: 04:00PM EST
Except for the one dog- The Estée Lauder Companies Inc. (EL)- China misfire//// NYSE - NYSE Delayed Price. 129.76-5.05(-3.75%) At close: 04:00PM EST